The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism

European Journal of Clinical Investigation

Volumn 39, Issue 1, 2009, Pages 43-50

  Willenberg, H S ^a   Kolentini, C ^a   Quinkler, M ^b   Cupisti, K ^a   Krausch, M ^a   Schott, M ^a   Scherbaum, W A ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adrenal; Aldosterone; Hypertension; Mineralocorticoid excess; SUSPPUP

Indexed keywords

ALDOSTERONE; POTASSIUM; RENIN; SODIUM;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL;

ALDOSTERONE; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MINERALOCORTICOIDS; POTASSIUM; RENIN; SODIUM; STATISTICS AS TOPIC;

EID: 57649198441     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.02060.x     Document Type: Article

References (25)

1. Fardella C, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile and molecular biology. J Clin Endocrinol Metab 2000 85 : 1863 7.
2. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004 89 : 1045 50.
3. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006 48 : 2293 300.
4. Bernini G, Moretti A, Argenio G, Salvetti A. Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur J Endocrinol 2002 146 : 523 9.
5. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 1981 141 : 1589 93.
6. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008 93 : 3266 81.
7. Mulatero P, Rabbia F, Milan F, Morello F, Veglio F, Chiandussi L et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002 40 : 897 902.
8. Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol 2002 57 : 457 65.
9. Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005 51 : 386 94.
10. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 2001 37 : 699 705.
11. Perschel FH, Schemer R, Seiler L, Reincke M, Deinum J, Maser-Gluth C et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem 2004 50 : 1650 5.
12. Hood S, Cannon J, Foo R, Brown M. Prevalence of primary aldosteronism assessed by aldosterone/renin ratio and spironolactone testing. Clin Med 2005 5 : 55 60.
13. Tiu S, Choi C, Shek C, Ng Y, Chan F, Ng C et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005 90 : 72 8.
14. Tanabe A, Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab 2003 88 : 2489 94.
15. Diederich S, Bidlingmaier M, Quinkler M, Reincke M. Diagnosis of primary hyperaldosteronism. Med Klin 2007 102 : 16 21.
16. Pietinen PI, Wong O, Atschul AM. Electrolyte output, blood pressure and family history of hypertension. Am J Clin Nutr 1979 32 : 997 1005.
17. Watson RL, Langford HG, Abernethy J, Barnes TY, Watson MJ. Urinary electrolytes, body weight and blood pressure. Pooled cross-sectional results among four groups of adolescent females. Hypertension 1980 2 : 93 8.
18. Watson RL, Langford HG. Weight, urinary electrolytes and blood pressure-results of several community based studies. J Chron Dis 1982 35 : 909 18.
19. Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab 2006 91 : 2618 23.
20. Schirpenbach C, Seiler L, Maser-Gluth C, Rüdiger F, Nickel C, Beuschlein F et al. Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. Eur J Endocrinol 2006 154 : 865 73.
21. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006 295 : 2638 45.
22. Catena C, Colussi GL, Nadalini E, Chiuch A, Baroselli S, Lapenna R et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008 168 : 80 5.
23. Lasaridis A, Brown JJ, Davies DL, Fraser R, Robertson JI, Lever AF. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension. J Hypertens 1984 2 : 329 36.
24. Beretta-Piccoli C, Davis DL, Brown JJ, Ferriss B, Fraser R, Lasaridis A et al. Relation of blood pressure with body and plasma electrolytes in Conn's syndrome. J Hypertens 1983 1 : 197 205.
25. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint task force of european and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 2004 173 : 381 91.